Intel lands massive Apple chip deal — momentum play on the big surge

Verdict: compelling story, broken setup — wait on the sidelines

Intel's Apple foundry deal is a genuine thesis catalyst — landing a domestic manufacturing contract from Apple validates the turnaround narrative the idea argues, and 36.1% year-over-year revenue growth with 26.1% R&D intensity places the company above most sector peers on the dimensions that matter for a foundry buildout. Against that, Intel is bleeding $4.9B in negative annual free cash flow (0th percentile among 580 IT peers), gross margin sits at just 34.8% versus the 58–65% range Intel maintained through the 2010s, and the exit rule is already live with price at $86.30 below the 9-period EMA at $87.69. Because of insufficient 1-hour price history, the EMA-and-volume rule set could not be backtested and no robust setup was established, so this rests on discretionary conviction rather than a demonstrated edge. The current setup is not actionable: the 9-period EMA trails the 21-period by roughly 3%, the nearest take-profit resistance at $85.00 is actually below the current price, and the risk-to-reward on the stated levels is negative. **Conviction breakdown** - **Thesis support: 58** — The Apple partnership is a legitimate inflection event, but the thesis depends on a single deal catalyzing sustained momentum rather than a one-day gap. - **Trade readiness: 12** — Neither entry condition is live, the exit rule is already triggered, and the support/resistance levels produce a negative reward-to-risk ratio at current prices. - **Risk quality: 28** — A 2.7% stop at $84.00 is tight given the stock's history of sharp post-event reversals, and the absence of any backtested drawdown data leaves risk unquantified. - **Fundamentals trend: 52** — Revenue growth and R&D intensity are strong, and Q3 2025 showed gross margin recovery to 38.2% with the first positive quarterly operating margin since 2022, but full-year free cash flow remains deeply negative and margins are near sector bottoms.

Trade now

Intel is trading at $86.30, but the entry conditions for this momentum strategy are not active — you should wait. The first condition requires the 9-period EMA to cross above the 21-period EMA. Right now the 9-period EMA sits at $87.69, about 3% below the 21-period EMA at $90.64. That gap needs to close via a sustained price push, not just a single hourly candle. The second condition requires volume to exceed 150% of the 10-period average; OBV data is currently unavailable, so that trigger cannot be confirmed live. Meanwhile, the strategy's own exit rule — price closing below the 9-period EMA — is already met, which tells you the immediate momentum is pointing down, not up. If the entry does trigger, the predefined risk levels are tight. The stop loss is placed below the second support level at $84.00, roughly 2.7% under the current price. The take-profit target is the nearest resistance at $85.00, which is actually *below* the current $86.30 close. Because the strategy's support/resistance levels are static and the stock has moved past them, the effective reward-to-risk ratio on these levels is currently negative — you would be risking more to the downside than you would gain to the upside. Any live entry would need a fresh upward cross that re-establishes meaningful distance above $90.64 first. A material scope note: because of insufficient 1-hour historical data, this strategy could not be backtested and no robust parameter setup was established. Treat the $84.00…

Scores

• Conviction score breakdown: 38
• Thesis support: 58
• Trade readiness: 12
• Risk quality: 28
• Fundamentals trend: 52

Watch items

• INTC — EMA (9) vs EMA (21) spread
• INTC — Hourly volume vs 10-period average
• INTC — RSI (14)
• INTC — Price vs 9-period EMA
• INTC — Support level (rank 2)
• INTC — Price vs 200-day average
• INTC — EMA (9) crossed above EMA (21)
• INTC — Price below EMA (9)